Furthermore, dysregulated the MEK5-ERK5 axis is associated with tumor growth, invasion, metastasis, poor prognosis, and therapeutic resistance in various tumor types such as breast cancer, prostate cancer, colon cancer, and lung cancer (14–19). The gene discussed is MAP2K5; the disease is neoplasm.